10.70
price up icon2.39%   0.25
after-market 시간 외 거래: 10.67 -0.03 -0.28%
loading
전일 마감가:
$10.45
열려 있는:
$10.595
하루 거래량:
289.79K
Relative Volume:
0.37
시가총액:
$736.28M
수익:
$46.02M
순이익/손실:
$-70.80M
주가수익비율:
-5.8791
EPS:
-1.82
순현금흐름:
$-1.61M
1주 성능:
+6.36%
1개월 성능:
+29.23%
6개월 성능:
+21.32%
1년 성능:
+11.87%
1일 변동 폭
Value
$10.55
$11.00
1주일 범위
Value
$10.00
$11.08
52주 변동 폭
Value
$3.91
$13.98

Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile

Name
명칭
Eyepoint Pharmaceuticals Inc
Name
전화
617-926-5000
Name
주소
480 PLEASANT STREET, WATERTOWN, MA
Name
직원
144
Name
트위터
@eyepointpharma
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
EYPT's Discussions on Twitter

EYPT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
EYPT
Eyepoint Pharmaceuticals Inc
10.70 719.08M 46.02M -70.80M -1.61M -1.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-17 개시 RBC Capital Mkts Outperform
2025-01-07 개시 Citigroup Buy
2024-10-16 개시 Scotiabank Sector Outperform
2024-08-28 개시 Jefferies Buy
2024-01-22 개시 JP Morgan Overweight
2023-11-02 개시 Mizuho Buy
2023-04-21 개시 Robert W. Baird Outperform
2022-07-07 개시 Chardan Capital Markets Buy
2021-03-01 개시 Cowen Outperform
2021-01-28 개시 Cantor Fitzgerald Overweight
2020-04-06 다운그레이드 B. Riley FBR Buy → Neutral
2019-11-04 재개 Laidlaw Buy
2019-09-12 개시 Guggenheim Buy
모두보기

Eyepoint Pharmaceuticals Inc 주식(EYPT)의 최신 뉴스

pulisher
01:50 AM

Is EyePoint Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com

01:50 AM
pulisher
Jul 22, 2025

What drives EyePoint Pharmaceuticals Inc. stock priceGame-changing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about EyePoint Pharmaceuticals Inc. stockTremendous return on equity - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

EyePoint Pharmaceuticals Inc. Stock Analysis and ForecastExplosive trading opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 563 - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Jul 16, 2025
pulisher
Jul 16, 2025

EyePoint Pharmaceuticals Awards 63,900 Shares in Employee Stock Options Under NASDAQ Rule - Stock Titan

Jul 16, 2025
pulisher
Jul 15, 2025

EyePoint Pharmaceuticals Acquisition by Federated Hermes Highlights Interest in Healthcare Sector - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

What makes EyePoint Pharmaceuticals Inc. stock price move sharplyFree Insider Trading Tips - beatles.ru

Jul 15, 2025
pulisher
Jul 14, 2025

Pleasing Signs As A Number Of Insiders Buy EyePoint Pharmaceuticals Stock - simplywall.st

Jul 14, 2025
pulisher
Jul 09, 2025

EyePoint Pharmaceuticals (EYPT) Soars 10.15% on Clinical Trial Progress - AInvest

Jul 09, 2025
pulisher
Jul 05, 2025

Trend Tracker for (EYPT) - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jun 30, 2025

EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 20, 2025

EyePoint Pharmaceuticals Approves Share Increase at Annual Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Initiates Coverage on EyePoint Pharmaceuticals (EYPT - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

EyePoint Pharmaceuticals (EYPT) Poised for Success with Positive Outlook | EYPT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Initiates EyePoint Pharmaceuticals at Outperform With $28 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

After Leaping 47% EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Are Not Flying Under The Radar - simplywall.st

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint (EYPT) Grants Stock Options to New Employees as Inducement | EYPT Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint Awards 12,500 Shares in Stock Options to Three New Hires at $9.03 Per Share - Stock Titan

Jun 16, 2025
pulisher
Jun 14, 2025

(EYPT) Trading Report - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 12, 2025

EyePoint Stock: Retaining My 'Risky Buy' CallPivotal Data Due Early 2026 (NASDAQ:EYPT) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on EYPT FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

EyePoint at Goldman Sachs Healthcare Conference: Sustained-Release Vision By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 09, 2025

Breakout Momentum Plays You May Not Know About - Investing.com

Jun 09, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Has $302,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Ameriprise Financial Inc. Grows Stock Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Raises Stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Cookies Notice - EyePoint Pharmaceuticals

Jun 03, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Buys 8,981 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

(EYPT) Investment Report - news.stocktradersdaily.com

Jun 01, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $276,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Eyepoint projects DURAVYU Phase 3 enrollment completion by H2 2025 amid strong clinical trial momentum - MSN

May 31, 2025
pulisher
May 31, 2025

Millennium Management LLC Buys New Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 31, 2025
pulisher
May 30, 2025

EyePoint advances with Duravyu Phase III trial - Yahoo

May 30, 2025

Eyepoint Pharmaceuticals Inc (EYPT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
자본화:     |  볼륨(24시간):